Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 31% ± 8% | |
| CD8-positive, alpha-beta T cell | 5 studies | 22% ± 4% | |
| natural killer cell | 4 studies | 23% ± 6% | |
| CD4-positive, alpha-beta T cell | 4 studies | 23% ± 7% | |
| endothelial cell | 3 studies | 21% ± 5% | |
| fibroblast | 3 studies | 22% ± 6% | |
| dendritic cell | 3 studies | 23% ± 1% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 23% ± 3% |
Insufficient scRNA-seq data for expression of NABP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 2388.49 | 258 / 258 | 100% | 52.06 | 230 / 230 |
| brain | 100% | 2312.22 | 2642 / 2642 | 100% | 82.53 | 705 / 705 |
| esophagus | 100% | 1440.10 | 1445 / 1445 | 100% | 55.52 | 183 / 183 |
| ovary | 100% | 1518.91 | 180 / 180 | 100% | 71.51 | 430 / 430 |
| pancreas | 100% | 1234.09 | 328 / 328 | 100% | 50.58 | 178 / 178 |
| thymus | 100% | 1382.96 | 653 / 653 | 100% | 56.77 | 605 / 605 |
| uterus | 100% | 1595.05 | 170 / 170 | 100% | 77.83 | 459 / 459 |
| skin | 100% | 1481.73 | 1808 / 1809 | 100% | 67.58 | 472 / 472 |
| intestine | 100% | 1618.62 | 966 / 966 | 100% | 75.94 | 526 / 527 |
| breast | 100% | 1382.27 | 459 / 459 | 100% | 68.96 | 1115 / 1118 |
| kidney | 100% | 1471.88 | 89 / 89 | 100% | 49.59 | 898 / 901 |
| prostate | 100% | 1404.70 | 245 / 245 | 100% | 51.33 | 500 / 502 |
| stomach | 100% | 1197.65 | 359 / 359 | 99% | 73.48 | 284 / 286 |
| liver | 100% | 779.01 | 225 / 226 | 100% | 40.18 | 404 / 406 |
| bladder | 100% | 1639.52 | 21 / 21 | 99% | 65.61 | 499 / 504 |
| lung | 99% | 1056.62 | 574 / 578 | 99% | 58.54 | 1149 / 1155 |
| adipose | 100% | 1278.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 45.81 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 76.49 | 29 / 29 |
| muscle | 100% | 1862.63 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1169.33 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 76.02 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 31.45 | 1 / 1 |
| blood vessel | 100% | 1514.44 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 944.85 | 842 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 79% | 929.27 | 733 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006281 | Biological process | DNA repair |
| GO_1904355 | Biological process | positive regulation of telomere capping |
| GO_0010212 | Biological process | response to ionizing radiation |
| GO_0006974 | Biological process | DNA damage response |
| GO_0051972 | Biological process | regulation of telomerase activity |
| GO_0007093 | Biological process | mitotic cell cycle checkpoint signaling |
| GO_0000724 | Biological process | double-strand break repair via homologous recombination |
| GO_0044818 | Biological process | mitotic G2/M transition checkpoint |
| GO_0070200 | Biological process | establishment of protein localization to telomere |
| GO_0070876 | Cellular component | SOSS complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0000781 | Cellular component | chromosome, telomeric region |
| GO_0035861 | Cellular component | site of double-strand break |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0070182 | Molecular function | DNA polymerase binding |
| GO_0003697 | Molecular function | single-stranded DNA binding |
| GO_0061730 | Molecular function | C-rich strand telomeric DNA binding |
| GO_0098505 | Molecular function | G-rich strand telomeric DNA binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NABP2 |
| Protein name | Nucleic acid binding protein 2 SOSS complex subunit B1 (Nucleic acid-binding protein 2) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2B) (Sensor of single-strand DNA complex subunit B1) (Sensor of ssDNA subunit B1) (SOSS-B1) (Single-stranded DNA-binding protein 1) (hSSB1) |
| Synonyms | LP3587 SSB1 OBFC2B |
| Description | FUNCTION: Component of the SOSS complex, a multiprotein complex that functions downstream of the MRN complex to promote DNA repair and G2/M checkpoint . In the SOSS complex, acts as a sensor of single-stranded DNA that binds to single-stranded DNA, in particular to polypyrimidines. The SOSS complex associates with DNA lesions and influences diverse endpoints in the cellular DNA damage response including cell-cycle checkpoint activation, recombinational repair and maintenance of genomic stability. Required for efficient homologous recombination-dependent repair of double-strand breaks (DSBs) and ATM-dependent signaling pathways. . |
| Accessions | ENST00000380198.6 [Q9BQ15-1] ENST00000399713.6 Q9BQ15 C9JT95 ENST00000341463.5 [Q9BQ15-1] ENST00000267023.9 [Q9BQ15-1] ENST00000447747.5 C9JMP5 |